← Back to Search

Magnetic Stimulation for Psychosis

Q: What are the eligibility requirements to participate in this investigation?

<p>Patients with diagnosed <a href="https://www.withpower.com/clinical-trials/schizophrenia">schizophrenia</a>, aged between 18 and 55 years old, are eligible to join this ongoing clinical trial. The research team aims to enrol roughly 95 patients in total.</p>

N/A

Waitlist Available

Research Sponsored by Mclean Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18-55 years

Diagnosis of a psychotic disorder (i.e. schizophrenia or schizoaffective disorder or bipolar disorder type I)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up eight minutes before tms and one minute after tms on each of the three tms visit days

Awards & highlights

Study Summary

This trial tests if magnetic stimulation can improve processing speed in people with psychotic disorders.

Who is the study for?

This trial is for adults aged 18-55 with a psychotic disorder (schizophrenia, schizoaffective disorder, or bipolar I). Participants must be stable outpatients who speak English and can complete study tasks. Exclusions include recent substance use disorders, certain brain conditions, metal implants not MRI-safe, pregnancy, seizure history, and progressive neurological diseases.Check my eligibility

What is being tested?

The study tests if magnetic stimulation (iTBS/cTBS) affects cognitive processing speed in psychosis. Participants will do problem-solving tasks and have brain scans before/after transcranial magnetic stimulation (TMS), which temporarily alters brain activity.See study design

What are the potential side effects?

While TMS is generally safe and FDA-approved for some conditions like depression and OCD, potential side effects may include discomfort at the stimulation site, headache, lightheadedness or seizures in very rare cases.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 55 years old.

Select...

I have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder type I.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ eight minutes before tms and one minute after tms on each of the three tms visit days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~eight minutes before tms and one minute after tms on each of the three tms visit days

This trial's timeline: 3 weeks for screening, Varies for treatment, and eight minutes before tms and one minute after tms on each of the three tms visit days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

BACS Digit Sequence test

BACS Symbol Coding test

functional Magnetic Resonance Imaging

Trial Design

3Treatment groups

Active Control

Placebo Group

Group I: continuous theta burst stimulation (cTBS)Active Control1 Intervention

Participants complete MRI scanning and cognitive testing followed by rTMS (cTBS pattern) followed by repeat cognitive testing and MRI scanning

Group II: Intermittent theta burst stimulation (iTBS)Active Control1 Intervention

Participants complete MRI scanning and cognitive testing followed by rTMS (iTBS pattern) followed by repeat cognitive testing and MRI scanning

Group III: sham rTMSPlacebo Group1 Intervention

Participants complete MRI scanning and cognitive testing followed by sham rTMS followed by repeat cognitive testing and MRI scanning

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterOTHER

837 Previous Clinical Trials

13,010,177 Total Patients Enrolled

21 Trials studying Schizophrenia

1,907 Patients Enrolled for Schizophrenia

Mclean HospitalLead Sponsor

213 Previous Clinical Trials

21,599 Total Patients Enrolled

19 Trials studying Schizophrenia

1,327 Patients Enrolled for Schizophrenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility requirements to participate in this investigation?

"Patients with diagnosed schizophrenia, aged between 18 and 55 years old, are eligible to join this ongoing clinical trial. The research team aims to enrol roughly 95 patients in total."

Answered by AI

Is this research including participants aged sixty or above?

"According to the criteria, patients aged between 18 and 55 are eligible for this trial. For minors, there are 161 studies available while those over 65 can take part in 484 clinical trials."

Answered by AI

Are there still enrollments available for participants in this clinical trial?

"The clinicaltrials.gov entry for this trial has not been updated since October 24th, 2023 and is therefore no longer recruiting patients at the present time. Luckily, there are 803 other studies actively seeking participants currently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cerebellar Modulation of Cognition in Psychosis

Kathryn Eve Lewandowski 2024. "Cerebellar Modulation of Cognition in Psychosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06107764.